Results 211 to 220 of about 224,404 (241)

Postmenopausal Estrogens and Endometrial Cancer

Ca-A Cancer Journal for Clinicians, 1977
Saul B Gusberg
exaly   +2 more sources

Postmenopausal Osteoporosis

New England Journal of Medicine, 2023
Elizabeth J Shane
exaly  

Human medicines European public assessment report (EPAR): Evista, raloxifene, Osteoporosis, Postmenopausal, Date of authorisation: 05/08/1998, Revision: 22, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Adrovance, alendronic acid / colecalciferol, Osteoporosis, Postmenopausal, Date of authorisation: 04/01/2007, Revision: 19, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Optruma, raloxifene, Osteoporosis, Postmenopausal, Date of authorisation: 05/08/1998, Revision: 23, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Osseor, strontium ranelate, Osteoporosis, Postmenopausal, Date of authorisation: 20/09/2004, Revision: 19, Status: Authorised

Case Medical Research, 2018
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Conbriza, bazedoxifene, Osteoporosis, Postmenopausal, Date of authorisation: 17/04/2009, Revision: 12, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Osteoporosis. Postmenopausal or secondary?

Hospital practice (Office ed.), 1985
B, Frame, M J, McKenna
openaire   +1 more source

Human medicines European public assessment report (EPAR): Zoledronic acid Teva Pharma, zoledronic acid, Osteoporosis,Osteitis Deformans,Osteoporosis, Postmenopausal, Date of authorisation: 15/08/2012, Revision: 11, Status: Withdrawn

Case Medical Research, 2018
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD), alendronic acid / colecalciferol, Osteoporosis, Postmenopausal, Date of authorisation: 16/10/2009, Revision: 13, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources